Bibliographic citations
Cóndor, J., (2022). Interacciones medicamentosas potenciales en pacientes del servicio de medicina del hospital Víctor Lazarte Echegaray, octubre 2018 - marzo 2019 [Universidad Nacional de Trujillo]. https://hdl.handle.net/20.500.14414/19573
Cóndor, J., Interacciones medicamentosas potenciales en pacientes del servicio de medicina del hospital Víctor Lazarte Echegaray, octubre 2018 - marzo 2019 []. PE: Universidad Nacional de Trujillo; 2022. https://hdl.handle.net/20.500.14414/19573
@misc{renati/1044326,
title = "Interacciones medicamentosas potenciales en pacientes del servicio de medicina del hospital Víctor Lazarte Echegaray, octubre 2018 - marzo 2019",
author = "Cóndor Goytizolo, José Martin",
publisher = "Universidad Nacional de Trujillo",
year = "2022"
}
ABSTRACT The main objective of this study was to characterize the potential drug interactions in medical prescriptions of patients of the Medicine service of the Víctor Lazarte Echegaray Hospital during the period from October 2018 to March 2019, for which data on medical prescriptions of 540 patients were collected. of the Medicine services (A, B, C and D) over 18 years of age with 7 days of hospitalization and with 2 or more medications. The data was entered into Microsoft Excel 2019 for further evaluation and analysis; Digital tools such as Drug Interaction Checker - Medscape Reference and Drugs.com were used to identify interactions, and SPSS v. 22.0 Demo and GraphPad Prism 7 Demo. These digital tools and programs made it possible to identify that on the first day of hospitalization, 58% of patients presented interactions and on the seventh day, 65.7%, that is, the number of drug interactions increased as the days of hospitalization increased; however, this increase was not significant with the variables sex and age (p>0.05). On the other hand, according to the number of medications, the frequency of interactions was significantly higher in prescriptions of 4 to 6 medications (p<0.05). In addition, in the 3 days of hospitalization analyzed, pharmacodynamic interactions and moderate severity predominated. These results allow identifying that a greater participation of the Pharmaceutical Chemist professional is necessary for the early identification and adequate management of drug interactions.
This item is licensed under a Creative Commons License